Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Swamirao Namdeo Shinde"'
Autor:
K.V. Vimalnath, Swamirao Namdeo Shinde, Sharad P. Lohar, Rajwardhan Ambade, M. S. A. Khan, Sudipta Chakraborty, Ashutosh Dash, P. V. Joshi, M. R. A. Pillai
Publikováno v:
Journal of Radioanalytical and Nuclear Chemistry. 303:451-467
The present article describes the development of an indigenous technology for large scale production of 131I based on the neutron irradiation of TeO2 target followed by the separation of 131I using dry distillation technique. In one batch, typically
Autor:
Kunal Purnachandra Muthe, Meera Venkatesh, Usha Pandey, Sanjay Saxena, Swamirao Namdeo Shinde, Yogendra Kumar, Ashutosh Dash
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 26:665-670
A facile, viable, "green" two-step, inexpensive technique was developed for the preparation of (32)P patch for the treatment of skin cancer. This technique consists of impregnation of H(3)(32)PO(4) solution into an inert solid carrier followed by imm
Autor:
S.D. Sharma, Swamirao Namdeo Shinde, S. Vandana, Y. S. Mayya, S. Mhatre, V S Shaiju, G Chourasiya
Publikováno v:
Applied Radiation and Isotopes. 69:130-135
Gafchromic films are increasingly being used for dosimetry in medical and industrial applications of ionizing radiation because of their favorable characteristics such as self developing in nature, easy to handle, dose rate independent response, inse
(131)I-Nimotuzumab - A potential radioimmunotherapeutic agent in treatment of tumors expressing EGFR
Autor:
Haladhar Dev Sarma, Swamirao Namdeo Shinde, Mythili Kameswaran, Meera Venkatesh, Ashutosh Dash, Grace Samuel
Publikováno v:
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 102
The anti-EGFR antibody Nimotuzumab was radioiodinated with I-131 by Chloramine T and Iodogen methods. The (131)I-Nimotuzumab was purified and characterized by HPLC. Purified (131)I-Nimotuzumab exhibited radiochemical purity of >95% and retained good
Autor:
Sanjay Kumar Saxena, Yogendra Kumar, Usha Pandey, Swamirao Namdeo Shinde, Kunal Purnachandra Muthe, Meera Venkatesh, Ashutosh Dash
Publikováno v:
Cancer Biotherapy & Radiopharmaceuticals; Oct2011, Vol. 26 Issue 5, p665-670, 6p